Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hilger JD"'
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up.
Autor:
Trotman J; Department of Haematology, Concord Repatriation General Hospital and Faculty of Medicine and Health, University of Sydney, Concord, NSW, Australia., Opat S; Clinical Haematology Unit, Monash Health and Monash University, Clayton, VIC, Australia., Gottlieb D; Faculty of Medicine and Health, University of Sydney, Westmead Hospital Sydney, Sydney, NSW, Australia., Simpson D; North Shore Hospital, Auckland, New Zealand.; BeiGene USA, Inc., San Mateo, CA., Marlton P; Department of Haematology, Princess Alexandra Hospital, Woolloongabba, Brisbane, QLD, Australia.; University of Queensland Faculty of Medicine, Brisbane, QLD, Australia., Cull G; Haematology Department, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.; Department of Lymphoma/Myeloma, University of Western Australia, Perth, WA, Australia., Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ., Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Roberts AW; Haematology Department, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia., Seymour JF; Haematology Department, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia., Atwal SK; BeiGene USA, Inc., San Mateo, CA., Yu Y; BeiGene (Shanghai) Co., Ltd., Shanghai, China; and., Novotny W; BeiGene USA, Inc., San Mateo, CA., Holmgren E; BeiGene USA, Inc., San Mateo, CA., Tan Z; BeiGene (Shanghai) Co., Ltd., Shanghai, China; and., Hilger JD; BeiGene USA, Inc., San Mateo, CA., Huang J; BeiGene USA, Inc., San Mateo, CA., Tam CS; Haematology Department, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.; St. Vincent's Hospital, Fitzroy, VIC, Australia.
Publikováno v:
Blood [Blood] 2020 Oct 29; Vol. 136 (18), pp. 2027-2037.
Autor:
Berenson JR; 1] Department of Hematology/Oncology, Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA [2] Oncotherapeutics, West Hollywood, CA, USA [3] James R Berenson, MD, Inc., West Hollywood, CA, USA., Hilger JD; Oncotherapeutics, West Hollywood, CA, USA., Yellin O; Oncotherapeutics, West Hollywood, CA, USA., Dichmann R; Department of Medical Oncology and Hematology, Central Coast Medical Oncology, Santa Maria, CA, USA., Patel-Donnelly D; Department of Hematology, Fairfax Northern Virginia Hematology Oncology, Fairfax, VA, USA., Boccia RV; Center for Cancer and Blood Disorders, Bethesda, MD, USA., Bessudo A; Department of Medical Oncology and Hematology, California Cancer Associates for Research and Excellence, Encinitas, CA, USA., Stampleman L; Pacific Cancer Care, Department of Medical Oncology & Hematology, Monterey, CA, USA., Gravenor D; Oncology Family Cancer Center Foundation, Memphis, TN, USA., Eshaghian S; Department of Internal Medicine, Hematology, and Oncology, Cedars-Sinai Medical Center, Los Angeles, USA., Nassir Y; Cancer Care Institute, Los Angeles, CA, USA., Swift RA; James R Berenson, MD, Inc., West Hollywood, CA, USA., Vescio RA; Department of Internal Medicine, Hematology, and Oncology, Cedars-Sinai Medical Center, Los Angeles, USA.
Publikováno v:
Leukemia [Leukemia] 2014 Jul; Vol. 28 (7), pp. 1529-36. Date of Electronic Publication: 2014 Jan 16.
Autor:
Berenson JR; Oncotherapeutics, Los Angeles, CA, USA, jberenson@imbcr.org., Hilger JD, Yellin O, Boccia RV, Matous J, Dressler K, Ghazal HH, Jamshed S, Kingsley EC, Harb WA, Noga SJ, Nassir Y, Swift RA, Vescio R
Publikováno v:
Annals of hematology [Ann Hematol] 2014 Jan; Vol. 93 (1), pp. 89-98. Date of Electronic Publication: 2013 Oct 18.
Autor:
Berenson JR; Oncotherapeutics, West Hollywood, CA 90069, USA. jberenson@imbcr.org, Yellin O, Kazamel T, Hilger JD, Chen CS, Cartmell A, Woliver T, Flam M, Bravin E, Nassir Y, Vescio R, Swift RA
Publikováno v:
Leukemia [Leukemia] 2012 Jul; Vol. 26 (7), pp. 1675-80. Date of Electronic Publication: 2012 Feb 22.
Autor:
Berenson JR; Oncotherapeutics, James R. Berenson, MD, Inc. Institute for Myeloma and Bone Cancer Research, 9201 W. Sunset Blvd., West Hollywood, CA 90069, USA. jberenson@imbcr.org, Yellin O, Chen CS, Patel R, Bessudo A, Boccia RV, Yang HH, Vescio R, Yung E, Mapes R, Eades B, Hilger JD, Wirtschafter E, Hilger J, Nassir Y, Swift RA
Publikováno v:
British journal of haematology [Br J Haematol] 2011 Dec; Vol. 155 (5), pp. 580-7. Date of Electronic Publication: 2011 Sep 26.
Autor:
Berenson JR; Institute for Myeloma and Bone Cancer Research, West Hollywood, California 90069, USA. jberenson@imbcr.org, Yellin O, Crowley J, Makary A, Gravenor DS, Yang HH, Upadhyaya GH, Flinn IW, Staszewski H, Tiffany NM, Sanani S, Farber CM, Morganstein N, Bolejack V, Nassir Y, Hilger JD, Sefaradi A, Shamouelian A, Swift RA
Publikováno v:
American journal of hematology [Am J Hematol] 2011 Jan; Vol. 86 (1), pp. 25-30.
Autor:
Kalar DJ; Department of Psychology, University of California, Los Angeles, CA, United States. donkalar@ucla.edu, Garrigan P, Wickens TD, Hilger JD, Kellman PJ
Publikováno v:
Vision research [Vision Res] 2010 Feb 08; Vol. 50 (3), pp. 284-99. Date of Electronic Publication: 2009 Oct 21.
Autor:
Fantoni C; Department of Psychology and B.R.A.I.N. Center for Neuroscience, University of Trieste, Italy. fantoni@psico.units.it, Hilger JD, Gerbino W, Kellman PJ
Publikováno v:
Journal of vision [J Vis] 2008 Nov 07; Vol. 8 (7), pp. 29.1-19. Date of Electronic Publication: 2008 Nov 07.